Kanagawa, Japan

Akira Sen

This inventor holds 1 USPTO granted patent. Top assignee: Morinaga Milk Industry Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Sen. Retrieved from https://idiyas.com/inventor/akira-sen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akira Sen: Innovator in Probiotic Obesity Treatment

Introduction

Akira Sen is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of obesity treatment through innovative use of probiotics. His work focuses on developing effective methods and compositions aimed at reducing body fat and waist circumference.

Latest Patents

Sen holds a patent for "Obesity treatment using probiotics, composition for reducing body fat, and composition for reducing waist circumference." This patent provides means, methods, and compositions that are effective for treating obesity using probiotics such as bifidobacteria or lactobacilli. It also includes a method for selecting probiotic bacteria that have a body fat-reducing effect, as well as a method for identifying responders to these probiotic bacteria with anti-obesity actions. The composition is particularly aimed at individuals in the pre-obesity group or those suffering from obesity, focusing on intestinal flora with a high ratio of the phylum Firmicutes to the phylum Bacteroidetes.

Career Highlights

Akira Sen is associated with Morinaga Milk Industry Co., Ltd., where he continues to advance research in the field of probiotics and obesity treatment. His innovative approach has garnered attention in both academic and commercial sectors.

Collaborations

Sen collaborates with Junichi Minami, who is a key figure in his research endeavors. Together, they work on developing and refining probiotic treatments for obesity.

Conclusion

Akira Sen's contributions to obesity treatment through probiotics represent a significant advancement in the field. His innovative methods and compositions have the potential to improve health outcomes for many individuals struggling with obesity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…